Understanding the immunology of the Zostavax shingles vaccine.
Sign Up to like & getrecommendations! Published in 2019 at "Current opinion in immunology"
DOI: 10.1016/j.coi.2019.02.005
Abstract: Zostavax is a live-attenuated varicella zoster virus (VZV) vaccine recommended for use in adults >50 years of age to prevent shingles. The main risk factor for the development of shingles is age, which correlates with… read more here.
Keywords: immunology zostavax; immunity; zostavax; understanding immunology ... See more keywords